TYPE 2 DIABETES + CARDIOVASCULAR RISKS

blood glocose meter.jpeg
obese couple laughing.jpeg
410474-PD37MS-492.jpg

If you are living with type 2 diabetes, it’s time to talk about your increased risk of cardiovascular events.
Fortunately, the SURPASS-CVOT clinical research study is currently underway in Salt Lake City. This study will be assessing the efficacy of a new investigational medication and its potential to prevent major adverse cardiovascular events in those with type 2 diabetes. 
To qualify for this study, you must:

 

To qualify for this study, you must:

•    be diagnosed with Type 2 Diabetes
•    be aged 40 or above
•    have established coronary artery disease, cerebrovascular disease, or peripheral arterial disease.
All those who participate will receive active medication. They will receive either investigational medication or dulaglutide (1.5 mg) to compare results​

We will provide to you at no cost:

  • Study-related medication

  • You will receive comprehensive labs, ECGs, Physical Exam etc. which we can forward to your PCP.

  • You will be compensated for your time and travel $50.00 for each office visit (once completed).

To find out more call or text us at (801) 657-3206 or submit the form below. By contacting us, you are in no way obligated to participate. All information submitted is kept strictly confidential and is never shared or sold to third parties.

Coronavirus (COVID-19)

What to expect when visiting Kalo Clinical Research as we begin to resume in-person patient visits. At this time, you can schedule a screening appointment for one of our clinical research trials...continue reading